Cybin Inc. (OTCMKTS:CLXPF – Get Free Report)’s stock price shot up 5.1% on Monday . The company traded as high as $0.38 and last traded at $0.37. 4,788,887 shares changed hands during mid-day trading, an increase of 768% from the average session volume of 551,962 shares. The stock had previously closed at $0.35.
Cybin Trading Up 5.1 %
The firm has a market cap of $54.68 million and a P/E ratio of -1.53. The firm’s 50 day moving average is $0.39 and its two-hundred day moving average is $0.41.
Cybin Company Profile
Cybin Inc, a life sciences company, focuses on developing psychedelic therapeutics to treat various psychiatric and neurological conditions. The company operates through two segments, Serenity Life and Natures Journey. The Serenity Life segment engages in the research and development of pharmaceutical and nutraceutical psilocybin products.
See Also
- Five stocks we like better than Cybin
- Investing in Commodities: What Are They? How to Invest in Them
- 3 CEO-Led Turnaround Stocks You Can Still Buy
- 3 Stocks to Protect Your Portfolio from the Coronavirus Contagion
- 3 Value Stocks You Can Buy Before They Become Big
- Using the MarketBeat Dividend Tax Calculator
- Chinese Stocks Stage Impressive Rebound
Receive News & Ratings for Cybin Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cybin and related companies with MarketBeat.com's FREE daily email newsletter.
